Firm Analyst
HC Wainwright
Joe Pantginis
Zacks SCR
John Vandermosten

BioLineRx is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding BioLineRx's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BioLineRx or its management. BioLineRx does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients